LearnGlossaryMarketStocksSuperinvestorsSign in

BIOQ

Bioqual, Inc.

Healthcare · $30M market cap

Verdict

Share price

$33.00

close of Oct 2, 2026

Fair value

$18.57

Sticker Price

Payback Price

$7.43

buy price

Overpriced

BIOQ is Overpriced: at $33.00 it trades 78% above its fair value of $18.57. Its buy price (Payback Price) is $7.43, 77% below today's price. Business quality is mixed: 2 of 5 key numbers clear the 10% bar.

How we valued it

Free Cash Flow. Sales grew -10% a year over the last 3 years, below the 15% we look for in a fast grower, so we value it on its free cash flow instead of an earnings forecast.

Business quality

2 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth11.4% a year✓
Equity per share growth10.7% a year✓
Sales growth6.9% a year✗
Free cash flow growth9.1% a year✗
Return on invested capital-0.5%✗

Follow BIOQ

Get notified when it reaches its buy price of $7.43. Free.

Create a free account

About Bioqual, Inc.

Bioqual, Inc. delivers a range of preclinical research solutions, encompassing both in-vivo and in-vitro methodologies, to its diverse clientele of commercial enterprises and government agencies across the United States. Their expertise spans numerous critical health domains, including investigations into COVID-19, AIDS, influenza, RSV infection, and various flaviviruses such as Zika and Dengue. Furthermore, their…

Medical - Diagnostics & Research

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 2, 2026. How the Payback Price works